
==== Front
Am J Case Rep
Am J Case Rep
amjcaserep
The American Journal of Case Reports
1941-5923
International Scientific Literature, Inc.

39192560
10.12659/AJCR.943013
943013
Articles
Malignant Pericardial Effusion from Cervical Squamous Cell Carcinoma: A Case Study
Sham Sunder A E F 1
Geetha Saroja Devi E F 2
Kawam Alae A B 3
Bendari Ahmed E 1
Al-Refai Reham E 1
Anjali F.N.U. E 4
Harshan Manju A 1
Das Kasturi A E 2
1 Department of Pathology and Laboratory Medicine, Northwell, Health Lenox Hill Hospital, New York City, NY, USA
2 Department of Pathology and Laboratory Medicine, Zucker School of Medicine, North Shore University Hospital/Long Island Jewish Medical Center, Northwell Health, Greenvale, NY, USA
3 Department of Pathology and Laboratory Medicine, Ameripath/Quest, Indianapolis, IN, USA
4 Department of Pathology and Laboratory Medicine, Sakhi Baba General Hospital, Sindh, Pakistan
Corresponding Author: Sunder Sham, e-mail: drsundersham@gmail.com
Authors’ Contribution:

A Study Design

B Data Collection

C Statistical Analysis

D Data Interpretation

E Manuscript Preparation

F Literature Search

G Funds Collection

Financial support: None declared

Conflict of interest: None declared

2024
28 8 2024
25 e943013-1e943013-5
29 10 2024
08 2 2024
18 7 2024
© Am J Case Rep, 2024
2024
https://creativecommons.org/licenses/by-nc-nd/4.0/ This work is licensed under Creative Common Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
Patient: Female, 42-year-old

Final Diagnosis: Metastatic squamous cell carcinoma

Symptoms: Cough • fever • shortness of breath

Clinical Procedure: —

Specialty: Pathology

Objective:

Rare coexistence of disease or pathology

Background:

Cervical cancer ranks fourth globally among women’s cancers. Squamous cell carcinoma constitutes 70% of cervical cancer cases, often metastasizing to lungs and paraaortic nodes. Uncommon sites include the brain, skin, spleen, and muscle, while pericardial fluid metastasis is highly rare. We report a case of squamous cell carcinoma of the uterine cervix that was metastatic to the pericardium and was detected on cytologic evaluation of pericardial fluid.

Case Report:

A 42-year-old woman who was previously treated for stage III squamous cell carcinoma of the cervix presented with symptoms of cough, fever, and shortness of breath for 8 days, and chest pain for 3 days. Clinical workup revealed pericardial effusion, with spread to the lungs and mediastinal and hilar lymph nodes. Cytological analysis of the fluid showed malignant cells, consistent with metastatic squamous cell carcinoma. Immunohistochemistry demonstrated cells positive for p63 and p40, while negative for GATA-3, D2-40, calretinin, and WT1. These findings in conjunction with patient’s known history of cervical squamous cell carcinoma was consistent with a cytologic diagnosis of metastatic squamous cell carcinoma to pericardial fluid.

Conclusions:

History and clinical correlation plays a vital role in determining the primary site causing malignant pericardial effusions. While the occurrence of cervical cancer metastasizing to the pericardium is uncommon, it should be considered, particularly in cases involving high-grade, invasive tumors, recurrences, or distant metastases. This possibility should be included in the list of potential diagnoses when encountering pericardial effusions with squamous cells in female patients.

Keywords:

Neoplasm Metastasis
Neoplasms, Squamous Cell
Pericardial Effusion
Uterine Cervical Neoplasms
==== Body
pmcIntroduction

Pericardial effusion results from diverse factors, including idiopathic cases, malignancy, uremia, iatrogenic factors, post-acute myocardial infarction situations, and infections. Malignancy contributes 13% of all cases [1]. Malignant pericardial involvement has been reported in 1% to 20% of cancer autopsies, with lung, breast, esophagus, melanoma, lymphoma, and leukemia as common sites of origin [2].

Cervical cancer is the fourth most common malignant tumor in women globally, with an annual mortality rate of approximately 311 000 deaths [3]. The disease metastasizes into surrounding tissues or distant organs by either direct filtration and/or by lymphatic and hematogenous pathways [4]. Cardiac metastasis from cervical cancer is extremely rare, with an estimated incidence of 1.23%, based on autopsy findings [5]. The diagnosis is typically made on post-mortem examination; only few cases of antemortem diagnosis of malignant pericardial effusion secondary to cervical carcinoma have been reported so far [6,7]. This could be due to low index of suspicion, asymptomatic involvement, and lack of advanced diagnostic techniques. The prognostic outlook subsequent to cardiac metastasis is unfavorable, and the most extended reported survival period following diagnosis is 13 months [8].

Here, we present a unique case of cervical carcinoma that metastasized to the pericardium, resulting in malignant pericar-dial effusion. The narrative delves into the pathological observations and cytomorphologic findings, with a focus on the use of immunohistochemistry (IHC) to distinguish from other close entities presenting with pericardial metastasis.

Case Report

A 42-year-old woman with history of stage III squamous cell carcinoma of the cervix and chemotherapy and radiation therapy presented with symptoms of cough, fever, and shortness of breath for 8 days, and chest pain for 3 days. The patient underwent a transthoracic echocardiogram, which revealed the presence of lesions in the lung, mediastinal and hilar lymph-adenopathy, and pericardial effusion. Pericardiocentesis was performed, and fluid samples were sent for cytopathologic evaluation. Cytopathology from pericardial fluid showed numerous pleomorphic cells present both as syncytial groups and isolated cells, with hyperchromatic nuclei and scant dense cytoplasm in a background of macrophages (Figures 1–3). Cell block demonstrated sheets of cells with hyperchromatic, enlarged nuclei, irregular nuclear contours, high nuclear to cytoplasmic ratio, and scant cytoplasm (Figure 4). On IHC, the malignant cells expressed p63, p40 (Figure 5), and were negative for GATA-3, D2-40, calretinin, and WT1. These morphologic and IHC features in conjunction with the history of squamous cell carcinoma of the cervix were compatible with metastatic cervical squamous cell carcinoma.

Discussion

Approximately 70% of cervical cancers are of squamous cell lesions [9] and are associated with human papillomavirus (HPV) [10]. Individuals harboring co-infections with other sexually transmitted organisms face an elevated risk of developing invasive cervical carcinoma. This risk is further heightened by recurrent cervicitis, oral contraceptive usage, tobacco consumption, and a compromised immune system [11]. In most cases, absence of these additional risk factors usually results in low-grade HPV infection, which usually self-resolves [10].

Although screening for cervical carcinoma has greatly reduced morbidity and mortality, this carcinoma is known to metastasize or recur. The recurrence rate of cervical carcinoma in women with no lymph node involvement following surgical intervention or radiotherapy is 10% to 20%. However, the recurrence rate stands at 70% in women who have had nodal metastasis. Metastasis of cervical carcinoma can occur via the lymphatic route or the hematogenous route, with the hematogenous route occurring more commonly in advanced stages, through the paracervical veins and the venous plexuses. The sites that are most commonly affected by distant metastasis are the lungs, which comprise 21% of distant metastatic sites, the para-aortic nodes, comprising 11%, the abdominal cavity, 8% and finally the supraclavicular nodes, which make up 7% of distant metastasis [4]. Unusual sites of metastasis include the breast, skin, soft tissue, umbilicus, and oral cavity [12]. In most cases, metastases occurs within 2 years of diagnosis [4]. The median survival time for metastatic cervical carcinoma is approximately 8 to 13 months. The 5-year survival rate is 16.5%. Furthermore, individuals exhibiting multi-site metastasis typically experience a markedly diminished survival rate than do patients with metastasis limited to a single site. [13].

Cardiac metastasis of cervical carcinoma is a very rare occurrence, with a reported incidence rate of approximately 1.23%. Due to the rarity of the condition, most cases are often discovered during autopsies. Very rarely, antemortem diagnosis of cardiac metastases is made. Prognosis is usually poor, with the longest reported survival being 13 months [5]. The primary locus of metastasis to the heart from cervical carcinoma predominantly involves the pericardium, accounting for 64% of all cardiac metastases, followed by the myocardium and endocardium. Intraventricular metastases have also been reported. Almost all intraventricular metastases occur in the right chamber [5].

Patients typically present with symptoms of pleuritic pain, cough, dyspnea, fatigue, and syncope. The mean age of diagnosis of pericardial effusion in the context of cervical carcinoma is 52 years. Diagnosis is made mostly in patients who have had prior identification of the primary tumor [14].

Cytological evaluation of the pericardial fluid is effective to assess for the presence of malignant cells. Indeed, cytological evaluation of pericardial fluid is a much better diagnostic tool for metastatic pericardial lesions than pericardial biopsies. Cytological evaluation has a false negativity rate of 14.7%, whereas the use of pericardial biopsy has a reported false negativity rate of 40% [15]. The differential diagnosis of cardiac metastases are thrombi, cardiac vegetations, and primary cardiac tumors, such as atrial myxoma, primary pericardial malignant mesothelioma [15,16]. Many times, it can be challenging to achieve a definitive diagnosis based solely on cyto-morphologic findings. In such context, application of IHC stains has demonstrated utility. Atrial myxomas are the most common primary tumors of the heart and typically present as a single, gelatinous, well-circumscribed mass [17]. Cytologic analysis of pericardial fluid reveals tumor cells that are spindle-shaped or polygonal, often with abundant cytoplasm and hyperchromatic nuclei [17]. In cases of malignant mesothelioma, the malignant cells usually form large clusters with a knobby, scalloped contour, referred to as mulberry clusters. The individual cells forming the clusters demonstrate cytomegaly, with a normal nuclear-cytoplasmic ratio. The nucleus is round and centrally located, with a prominent nucleolus. Binucleated and multinucleated cells are common [18]. Table 1 describes the IHC findings of atrial myxoma, malignant mesothelioma, and metastatic squamous cell carcinoma [19–22].

The cytologic evaluation of pericardial fluid in our study demonstrated pleomorphic cells with hyperchromatic, enlarged nuclei, which was concerning for malignancy. Although the patient had a history of cervical carcinoma, it was not in our top differentials, as cervical carcinoma metastasizing to the pericardium is extremely uncommon. We used a broad panel of IHC but found out that the tumor cells were only positive for p63 and p40, thereby pointing toward a diagnosis of meta-static cervical squamous cell carcinoma.

Conclusions

Although cervical cancer metastasizing to the pericardium is rare, it should be considered in patients with cervical cancer presenting with pericardial effusion, especially in patients with no other cause of pericardial effusion or a history of other malignancy. The prognosis of metastatic cervical carcinoma to the pericardium is generally poor, with a median survival time of only a few months. This case highlights the importance of considering the possibility of metastatic disease in the differential diagnosis of pericardial effusions and the value of IHC in the confirmatory diagnosis of metastatic tumors.

Figure 1. A small 3-dimensional cluster of cells with scant cytoplasm, enlarged hyperchromatic cells with nuclear overlapping, irregular nuclear contours, and high N: C ratios. Cytology smear, DQ stain, 60×.

Figure 2. A cluster of atypical cells with scant dense cytoplasm, hyperchromatic nuclei, irregular nuclear contours, and high N: C ratio. The cytoplasm of the cells in the cluster demonstrates orangephilia. Cytology smear, Pap stain, 60×.

Figure 3. Sheets of cells with scant dense cytoplasm, enlarged hyperchromatic nuclei, irregular nuclear contours high N: C ratio. Note tumor diathesis at the periphery of the cluster. Cytology smear, DQ stain, 60×.

Figure 4. (A) Cell block demonstrating a hypercellular specimen with sheets of cells (hematoxylin and eosin 20×). (B) The cells have enlarged nuclei with irregular nuclear contours, high N: C ratios, and scant cytoplasm (hematoxylin and eosin, 40×).

Figure 5. Cell block. (A) Strong and diffuse nuclear staining with p63 (20×). (B) Strong nuclear staining with p40 (20×).

Table 1. Immunohistochemical findings of atrial myxoma, malignant mesothelioma, metastatic squamous cell carcinoma.

Immunohistochemistry	Atrial myxoma	Malignant mesothelioma	Metastatic squamous cell carcinoma	
Vimentin	Positive	Positive	Negative	
Cytokeratin	Negative	Positive	Positive	
Desmin	Negative	Positive	Negative	
CD34	Positive	Negative	Negative	
bcl-2	Positive	Negative	Negative	
p63	Negative	Negative	Positive	
p40	Negative	Negative	Positive	
Calretinin	Negative	Positive	Negative	
D2–40	Negative	Positive	Negative	

Publisher’s note: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher

Declaration of Figures’ Authenticity

All figures submitted have been created by the authors who confirm that the images are original with no duplication and have not been previously published in whole or in part.
==== Refs
References:

1. Sagristà-Sauleda J Mercé J Permanyer-Miralda G Soler-Soler J Clinical clues to the causes of large pericardial effusions Am J Med 2000 109 2 95 101 10967149
2. Babu RS Lanjewar A Jadhav U A case series of malignant pericardial effusion J Family Med Prim Care 2022 11 10 6581 85 36618249
3. Sung H Ferlay J Siegel RL Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries Cancer J Clin 2021 71 3 209 49
4. Bhandari V Kausar M Naik A Batra M Unusual metastasis from carcinoma cervix J Obstet Gynaecol India 2016 66 5 358 62
5. Sasidharan A Hande V Mahantshetty U Shrivastava SK Cardiac metastasis in cervical cancer BJR Case Rep 2016 2 2 20150300 30363533
6. Rieke JW Kapp DS Successful management of malignant pericardial effusion in metastatic squamous cell carcinoma of the uterine cervix Gynecol Oncol 1988 31 2 338 51 3049263
7. Nelson BE Rose PG Malignant pericardial effusion from squamous cell cancer of the cervix J Surg Oncol 1993 52 3 203 6 8441281
8. Byun SW Park ST Ki EY Intracardiac metastasis from known cervical cancer: A case report and literature review World J Surg Oncol 2013 11 107 23702302
9. Hu K Wang W Liu X Comparison of treatment outcomes between squamous cell carcinoma and adenocarcinoma of cervix after definitive radiotherapy or concurrent chemoradiotherapy Radiat Oncol 2018 13 1 249 30558636
10. Cohen PA Jhingran A Oaknin A Denny L Cervical cancer Lancet 2019 393 10167 169 82 30638582
11. Ghosh I Mandal R Kundu P Biswas J Association of genital infections other than human papillomavirus with pre-invasive and invasive cervical neoplasia J Clin Diagn Res 2016 10 2 XE01 XE06
12. Yu X Wang Z Zhang Z Postoperation of cervical cancer with intestine metastasis: A case report and literature review World J Surg Oncol 2016 14 1 2 26739660
13. Zhou S Peng F Patterns of metastases in cervical cancer: A population-based study Int J Clin Exp Pathol 2020 13 7 1615 23 32782680
14. Rodríguez-Rosales YE Salazar-Mejía CE Soto-Martínez BA Cardiac tamponade as an initial manifestation of cervical cancer Case Rep Oncol Med 2019 2019 7524797 30729054
15. Burazor I Aviel-Ronen S Imazio M Metastatic cardiac tumors: From clinical presentation through diagnosis to treatment BMC Cancer 2018 18 1 202 29463229
16. Lee MJ Kim DH Kwan J A case of malignant pericardial mesothelioma with constrictive pericarditis physiology misdiagnosed as pericardial metastatic cancer Korean Circ J 2011 41 6 338 41 21779289
17. Anvari MS Boroumand MA Karimi A Histopathologic and clinical characterization of atrial myxoma: A review of 19 cases Lab Med 2009 40 10 596 99
18. Lagrotteria DD Tsang B Elavathil LJ Tomlinson CW A case of primary malignant pericardial mesothelioma Can J Cardiol 2005 21 2 185 87 15729420
19. Gong W Ye X Shi K Zhao Q Primary malignant pericardial mesothelioma – a rare cause of superior vena cava thrombosis and constrictive pericarditis J Thorac Dis 2014 6 12 E272 75 25590007
20. Hernández-Bringas O Ortiz-Hidalgo C [Histopathological and immunohisto-chemical features of cardiac myxomas.] Arch Cardiol Mex 2013 83 3 199 208 [in Spanish] 23663893
21. Wang JG Li YJ Liu H Clinicopathologic analysis of cardiac myxomas: Seven years’ experience with 61 patients J Thorac Dis 2012 4 3 272 83 22754666
22. Pereira TC Share SM Magalhães AV Silverman JF Can we tell the site of origin of metastatic squamous cell carcinoma? An immunohistochemical tissue microarray study of 194 cases Appl Immunohistochem Mol Morphol 2011 19 1 10 14 20823766
